Arrowstreet Capital
QGENF

Arrowstreet Capital’s QIAGEN NV QGENF Stock Holding History

Arrowstreet Capital’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-838,016
Closed -$21.6M – 1727
2015
Q3 		$21.6M Buy
838,016
+360,898
+76% +$9.31M 0.1% 201
2015
Q2 		$11.8M Buy
477,118
+463,618
+3,434% +$11.5M 0.07% 238
2015
Q1 		$340K Sell
13,500
-499,093
-97% -$12.6M ﹤0.01% 893
2014
Q4 		$12M Sell
512,593
-378,676
-42% -$8.88M 0.07% 276
2014
Q3 		$20.3M Buy
+891,269
New +$20.3M 0.11% 191
2014
Q2 		– Sell
-1,095,848
Closed -$23.1M – 1382
2014
Q1 		$23.1M Buy
1,095,848
+1,073,535
+4,811% +$22.6M 0.14% 162
2013
Q4 		$531K Buy
+22,313
New +$531K ﹤0.01% 960

Other funds holding QGENF

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Arrowstreet Capital's QGENF Position: Q4 2015 in Review

Arrowstreet Capital sold out of QIAGEN NV (QGENF) in Q4 2015, closing a stake of 838,016 shares — an estimated $21.6M sold.

Arrowstreet Capital first reported a position in QGENF in Q4 2013 and held it in 7 quarters. The position peaked at $23.1M in Q1 2014. 191 funds tracked by Wall St. Rank hold QGENF as of Q4 2015.

  • Arrowstreet Capital reported no remaining QIAGEN NV position as of Q4 2015 after selling out during the quarter.
  • Arrowstreet Capital sold 838,016 QIAGEN NV shares in Q4 2015, an estimated $21.6M.
  • Arrowstreet Capital first reported a position in QIAGEN NV in Q4 2013 and held it in 7 quarters.
  • Arrowstreet Capital's QIAGEN NV position peaked at $23.1M in Q1 2014.
  • 191 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2015.

Based on Arrowstreet Capital's 13F filing for Q4 2015, filed 16 Feb 2016.